Reproducibility and Rigor in Animal-Based Research

被引:58
作者
Macleod, Malcolm [1 ]
Mohan, Swapna [2 ,3 ]
机构
[1] Univ Edinburgh, Ctr Clin Brain Sci, 49 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland
[2] NIH, 8600 Rockville Pike, Bethesda, MD USA
[3] NIH, Div Policy & Educ, NIH Off Lab Anim Welf, Bldg 10, Bethesda, MD 20892 USA
关键词
rigor; reproducibility; research improvement activity; risks of bias; research ethics; METAANALYSIS; GUIDELINES; EFFICACY; NXY-059; MODELS; WASTE; BIAS;
D O I
10.1093/ilar/ilz015
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Increasing focus on issues of research reproducibility affords us the opportunity to review some of the key issues related in vivo research. First, we set out some key definitions, to guide the reader through the rest of the paper. Next we consider issues of epistemology, of how animal experiments lead to changes in our understanding of biomedicine and, potentially, to the development of new therapeutics. Here we consider the meaning of statistical significance; the importance of understanding whether findings have general truth; and the advances in knowledge which can result from 'failed' replication. Then, we consider weaknesses in the design, conduct and reporting of experiments, and review evidence for this from systematic reviews and from experimental studies addressing these issues. We consider the impact that these weaknesses have on the development of new treatments for human disease, and reflect on the response to these issues from the biomedical research community. Finally, we consider strategies for improvement including increased use of brief, pre-registered study protocols; pre-registration, open publication and open data; and the central importance of education in improving research performance.
引用
收藏
页码:17 / 23
页数:7
相关论文
共 48 条
  • [1] [Anonymous], 2019, NATURE, V570, P5, DOI 10.1038/d41586-019-01726-1
  • [2] [Anonymous], BIORXIV
  • [3] [Anonymous], 2011, GUID DESCR AN RES SC
  • [4] [Anonymous], 2013, NATURE, P496
  • [5] Attarwala H, 2010, J Young Pharm, V2, P332, DOI 10.4103/0975-1483.66810
  • [6] Two Years Later: Journals Are Not Yet Enforcing the ARRIVE Guidelines on Reporting Standards for Pre-Clinical Animal Studies
    Baker, David
    Lidster, Katie
    Sottomayor, Ana
    Amor, Sandra
    [J]. PLOS BIOLOGY, 2014, 12 (01)
  • [7] Raise standards for preclinical cancer research
    Begley, C. Glenn
    Ellis, Lee M.
    [J]. NATURE, 2012, 483 (7391) : 531 - 533
  • [8] Lack of blinding of outcome assessors in animal model experiments implies risk of observer bias
    Bello, Segun
    Krogsboll, Lasse T.
    Gruber, Jan
    Zhao, Zhizhuang J.
    Fischer, Doris
    Hrobjartsson, Asbjorn
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2014, 67 (09) : 973 - 983
  • [9] Criminalization of scientific misconduct
    Bulow, William
    Helgesson, Gert
    [J]. MEDICINE HEALTH CARE AND PHILOSOPHY, 2019, 22 (02) : 245 - 252
  • [10] Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
    Castellarin, Mauro
    Warren, Rene L.
    Freeman, J. Douglas
    Dreolini, Lisa
    Krzywinski, Martin
    Strauss, Jaclyn
    Barnes, Rebecca
    Watson, Peter
    Allen-Vercoe, Emma
    Moore, Richard A.
    Holt, Robert A.
    [J]. GENOME RESEARCH, 2012, 22 (02) : 299 - 306